chartexchange

TARA
Protara Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
2.34USD+0.862%(+0.02)1,149,663
After-hoursNov 18, 2026 4:00:30 PM EST
2.34USD0.000%(0.00)
Loading…
Loading…
144.07M
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$2.32
Beta
1.35
52-Week High
$7.82 2025-11-24
52-Week Low
$2.09 2026-11-06
SMA 50
$2.80
SMA 200
$4.31
Avg. Vol 10D
783,081
Avg. Vol 30D
920,198
Avg. Vol 90D
851,778
Relative Vol
1.25
54.38M
0.3100%
1,500,000
TARA Profile

protara therapeutics, inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. the company's lead program is tara-002, an investigational cell therapy for the treatment of lymphatic malformations. it also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. the company was formerly known as artara therapeutics, inc. and changed its name to protara therapeutics, inc. in may 2020. protara therapeutics, inc. is based in new york, new york.

TARA Performance
PeriodPriceDateChangeBeta
1W2.442026-11-12-4.10%5.236
1M2.332026-10-19+0.43%2.547
3M3.962026-08-19-40.91%2.056
6M4.342026-05-19-46.08%1.577
1Y6.712025-11-19-65.13%1.351
2Y2.322024-11-19+0.86%—
5Y7.202021-11-19-67.50%1.138
TARA Stock Summary

Protara Therapeutics, Inc. Common Stock (NASDAQ:TARA) stock price today is $2.34, and today's volume is 1,149,663. TARA is up 0.862% today. The 30 day average volume is 920,198. TARA market cap is $144.07M with 61.57M shares outstanding.